Decentralized clinical trials - A more patient-centric approach

Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.


Open PDF

Return to Insights Center

Related Insights

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Video

The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?

Feb 1, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Video

The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs

Aug 22, 2024

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Podcast

Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Related Insights

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Video

The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?

Feb 1, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Show more